felodipine has been researched along with Bilateral Headache in 9 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to compare the tolerability of isradipine and felodipine in patients with mild-to-moderate hypertension." | 9.07 | A multicenter comparison of isradipine and felodipine in the treatment of mild-to-moderate hypertension. The Physician's Study Group. ( Cutler, SA; Hammond, JJ, 1993) |
| " She complained headache and a treatment of 20 mg nicergoline (ergoline derivate) daily was started." | 7.72 | [Nicergoline-induced Prinzmetal angina. "Heartache" instead of headache]. ( Tátrai, T; Tomcsányi, J; Vecsey, T, 2004) |
| "1%) were the clinical adverse experiences most often reported in patients treated with losartan." | 6.68 | Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. ( Dunlay, MC; Goldberg, AI; Sweet, CS, 1995) |
| "The objective of this study was to compare the tolerability of isradipine and felodipine in patients with mild-to-moderate hypertension." | 5.07 | A multicenter comparison of isradipine and felodipine in the treatment of mild-to-moderate hypertension. The Physician's Study Group. ( Cutler, SA; Hammond, JJ, 1993) |
| " She complained headache and a treatment of 20 mg nicergoline (ergoline derivate) daily was started." | 3.72 | [Nicergoline-induced Prinzmetal angina. "Heartache" instead of headache]. ( Tátrai, T; Tomcsányi, J; Vecsey, T, 2004) |
| "The primary aim of this double-blind, parallel group trial was to compare incidence of newly occurring vasodilatory adverse events in elderly patients treated with recommended once-daily doses of felodipine extended release (ER) or amlodipine." | 2.69 | Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study Group. ( Aldons, PM; Burgess, ED; Girerd, X; Morgan, TO; Rehn, L; Schaefer, RM; Singh, GP; Tilvis, R, 1998) |
| " Neither AUC nor trough levels of FEL and AML were significantly influenced by transit times, nor was Cmax after any of the three treatments." | 2.69 | The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times. ( Laufen, H; Riedel, KD; Scharpf, F; Schumacher, T; Yeates, R; Zimmermann, T, 1999) |
| "1%) were the clinical adverse experiences most often reported in patients treated with losartan." | 2.68 | Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. ( Dunlay, MC; Goldberg, AI; Sweet, CS, 1995) |
| "1%) were the most commonly reported clinical adverse experiences in patients treated with losartan." | 2.39 | Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors. ( Dunlay, MC; Goldberg, AI; Sweet, CS, 1995) |
| " This study aimed to elucidate the impact of SMS on nifedipine/felodipine treatment by the findings from rat pharmacokinetic study of nifedipine to the retrospective cohort study of patients with hypertension." | 1.72 | Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment. ( Chen, WC; Chia-Hui Tan, E; Chiang, TY; Shen, CC; Ueng, YF; Wang, HJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, HJ | 1 |
| Chia-Hui Tan, E | 1 |
| Chiang, TY | 1 |
| Chen, WC | 1 |
| Shen, CC | 1 |
| Ueng, YF | 1 |
| Goldberg, AI | 2 |
| Dunlay, MC | 2 |
| Sweet, CS | 2 |
| Tomcsányi, J | 1 |
| Vecsey, T | 1 |
| Tátrai, T | 1 |
| Cutler, SA | 1 |
| Hammond, JJ | 1 |
| Wiklund, I | 1 |
| Halling, K | 1 |
| Rydén-Bergsten, T | 1 |
| Fletcher, A | 1 |
| Schaefer, RM | 1 |
| Aldons, PM | 1 |
| Burgess, ED | 1 |
| Tilvis, R | 1 |
| Girerd, X | 1 |
| Singh, GP | 1 |
| Rehn, L | 1 |
| Morgan, TO | 1 |
| Zimmermann, T | 1 |
| Laufen, H | 1 |
| Yeates, R | 1 |
| Scharpf, F | 1 |
| Riedel, KD | 1 |
| Schumacher, T | 1 |
| Groom, P | 1 |
| Simpson, RJ | 1 |
| Singh, B | 1 |
| Ward, DE | 1 |
| Peers, E | 1 |
| Richardson, PD | 1 |
1 review available for felodipine and Bilateral Headache
| Article | Year |
|---|---|
Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers | 1995 |
6 trials available for felodipine and Bilateral Headache
| Article | Year |
|---|---|
Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Conver | 1995 |
A multicenter comparison of isradipine and felodipine in the treatment of mild-to-moderate hypertension. The Physician's Study Group.
Topics: Adult; Ankle; Double-Blind Method; Drug Therapy, Combination; Edema; Enalapril; Felodipine; Female; | 1993 |
Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study.
Topics: Affect; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Ankle; Blood Pressure; Ca | 1997 |
Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study Group.
Topics: Aged; Amlodipine; Antihypertensive Agents; Delayed-Action Preparations; Dizziness; Double-Blind Meth | 1998 |
The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times.
Topics: Adult; Amlodipine; Area Under Curve; Biological Availability; Calcium Channel Blockers; Cross-Over S | 1999 |
A double-blind comparison of felodipine and hydrochlorothiazide added to metoprolol to control hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Dizziness; Double-Bl | 1988 |
2 other studies available for felodipine and Bilateral Headache
| Article | Year |
|---|---|
Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment.
Topics: Animals; Cytochrome P-450 CYP3A; Drug Combinations; Drugs, Chinese Herbal; Felodipine; Headache; Hum | 2022 |
[Nicergoline-induced Prinzmetal angina. "Heartache" instead of headache].
Topics: Angina Pectoris, Variant; Dyspnea; Felodipine; Female; Headache; Humans; Middle Aged; Nicergoline; N | 2004 |